Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on WAVE Life Sciences (NASDAQ:WVE) in the last three months.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 1 | 1 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 1 | 0 | 0 | 0 | 0 |
| 3M Ago | 2 | 0 | 1 | 0 | 0 |
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $13.4, along with a high estimate of $19.00 and a low estimate of $5.00. This current average reflects an increase of 14.82% from the previous average price target of $11.67.
Deciphering Analyst Ratings: An In-Depth Analysis
A comprehensive examination of how financial experts perceive WAVE Life Sciences is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Tiago Fauth | Wells Fargo | Announces | Overweight | $11.00 | – |
| Joon Lee | Truist Securities | Maintains | Buy | $17.00 | $17.00 |
| Salim Syed | Mizuho | Raises | Buy | $19.00 | $10.00 |
| Luca Issi | RBC Capital | Maintains | Sector Perform | $5.00 | – |
| Andrew Fein | HC Wainwright & Co. | Raises | Buy | $15.00 | $8.00 |
Key Insights:
Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they ‘Maintain’, ‘Raise’ or ‘Lower’ their stance, it reflects their response to recent developments related to WAVE Life Sciences. This information provides a snapshot of how analysts perceive the current state of the company.
Rating: Gaining insights, analysts provide qualitative assessments, ranging from ‘Outperform’ to ‘Underperform’. These ratings reflect expectations for the relative performance of WAVE Life Sciences compared to the broader market.
Price Targets: Analysts navigate through adjustments in price targets, providing estimates for WAVE Life Sciences’s future value. Comparing current and prior targets offers insights into analysts’ evolving expectations.
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into WAVE Life…
Click Here to Read the Full Original Article at Cryptocurrencies Feed…
